Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Spero Therapeutics Inc
SPRO
Healthcare
Biotechnology
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company’s product candidates include Tebipenem HBr (tebipenem pivoxil hydrobromide), an oral carbapenem-class antibiotic to treat complicated urinary tract infections...
, including pyelonephritis for adult patients, which is in Phase 3 development; and SPR720, a novel product candidate for first-line treatment of nontuberculous mycobacterial (NTM) pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; and Vertex Pharmaceuticals Incorporated for patents relating to the oral prodrug SPR720, as well as SPR719, an active metabolite. Spero Therapeutics, Inc. was founded in 2013 a...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:SPRO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 22, 2022 10:33am
SPRO .....That';s more like it
Nice wait for it
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 22, 2022 10:21am
SPRO .....it broke the high..... N>H>O>D
Now rocket u beotch !!!!! Vols are increasing ; )
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 22, 2022 10:20am
SPRO .....Looking Real good......
wait for it
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 22, 2022 10:12am
SPRO .... What I like about this one is .....
There is a big gap if ....and thats a big if .....it can break $2.33 I only have a small position....just in case ; ) Iy 1st has to break $1.96 & $2.10 which are now resistance & prvious
...more
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 22, 2022 10:07am
SPRO ....early a.m runner on watch
Here a clip of the News Release...... GSK and Spero Therapeutics Announce Exclusive License Agreement for Late-Stage Antibiotic Asset, Tebipenem HBr 2022-09-21 23:00 ET - News
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Alvopetro 2025 Year End Reserves Includes a 79% Increase in Reserves & Replacement Ratio of 530%
Sorrento Resources Identifies Several High-Grade Soil Gold Anomalies up to 525m by 450m in Size, Newfoundland
Spanish Mountain Receives Positive Particle Ore Sorting Results Highlighting Production Upside
Tungsten has quietly become one of the most strategic metals on the planet
TomaGold Initiates Major Phase 2 Program at Berrigan Mine to Test Berrigan Deep Potential
Cielo Closes Private Placement Previously Announced in Connection with Strategic Asset Acquisition
Podcasts